Seizert Capital Partners, Llc
Source: SEC Form 13F · as of Mar 2026Seizert Capital Partners, Llc holds 17 biotech & pharma companies tracked by BioSniper, totaling $319.4M in value as of Mar 2026 (SEC Form 13F).
Companies held
17
Total value held
$319.4M
| Company | Shares | Value |
|---|---|---|
| REGNREGENERON PHARMACEUTICALS, INC. | 85,681 | $66.2M |
| UTHRUNITED THERAPEUTICS Corp | 104,667 | $62.1M |
| BMYBRISTOL MYERS SQUIBB CO | 729,793 | $44.3M |
| JNJJOHNSON & JOHNSON | 171,341 | $41.9M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 132,896 | $36.0M |
| ELVElevance Health Inc. | 120,839 | $35.4M |
| NBIXNEUROCRINE BIOSCIENCES INC | 87,660 | $11.5M |
| AMGNAMGEN INC | 19,337 | $6.8M |
| INCYIncyte Corp. | 67,559 | $6.4M |
| GILDGILEAD SCIENCES, INC. | 37,822 | $5.3M |
| MMSIMerit Medical Systems Inc. | 26,739 | $1.8M |
| MRKMerck & Co., Inc. | 4,230 | $509K |
| UTMDUtah Medical Products Inc. | 5,436 | $337K |
| CPRXCATALYST PHARMACEUTICALS, INC. | 13,500 | $334K |
| MCKMcKesson Corporation | 331 | $286K |
| BVSBioventus Inc. | 24,758 | $226K |
| BHCBausch Health Companies Inc. | 20,053 | $108K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.